Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Virtual

May 04, 2023 9:00 AM - May 05, 2023 1:00 PM

(Central Europe Standard Time)

eXtended EudraVigilance Medicinal Product Dictionary for Sponsors virtual training course

Virtual training course on how to submit and retrieve medicinal product data using EVWEB/ XEVMPD (Art 57 database) for investigational medicinal products.

Overview

Sponsors of clinical trials are responsible for providing information on Investigational Medicinal Products (IMPs) in the eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) in accordance with the CT-3 detailed guideline on the collection, verification and presentation of adverse event/reaction reports arising from clinical trials on medicinal products for human use (“CT-3”, chapter 7.9, paragraph 104).

The EMA has prepared this live virtual training course to facilitate the practical implementation of the requirements including technical aspects and all related procedures on electronic submission of information on development medicinal products (DMPs) by commercial and non-commercial sponsors of clinical trials in the European Economic Area (EEA).

The training focuses on explaining the guidance and mandatory data elements necessary for the electronic submission of information on development medicinal products (DMPs), applying the format of the eXtended EudraVigilance Product Report Message (XEVPRM) and the use of the XEVMPD data entry tool (EVWEB). It includes practical exercises in EVWEB for the electronic submission and maintenance of development medicinal product information.

Participants, who successfully pass the knowledge evaluation following the training course, will receive a notification of successful completion of this training course from the European Medicines Agency. This notification is requested from at least one user from the sponsor organisation during the registration with EudraVigilance for the electronic submission of information on DMPs. The aim is to ensure the quality of data submitted to the XEVMPD.

 

Who should attend?

This XEVMPD training programme is intended for commercial and non-commercial sponsors of clinical trials.

 

Learning objectives

At the conclusion of this training course participants will be able to:

  • Understand the requirements for sponsors of clinical trials as outlined in the Detailed guidance on the collection, verification and presentation of adverse event/reaction reports arising from clinical trials on medicinal products for human use’ (‘CT-3’) (OJ 2011/C 172/01)
  • Use the eXtended EudraVigilance Product Report Message (XEVPRM) format used for electronic submission of information on investigational medicinal products
  • Understand the controlled vocabularies and terminologies to be used during the submission process
  • Use the XEVPRM data entry tool (EVWEB) for the electronic submission and maintenance of DMPs
  • Explain the data structure of the eXtended EudraVigilance Product Dictionary (XEVMPD) for data entry and data retrieval
  • Understand the importance of the XEVMPD to support the submission of clinical trial information in the Clinical Trials Information System (CTIS)

 

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.